← Back to headlines
AstraZeneca Faces Scrutiny After Drug Trial Failure and Share Slide
AstraZeneca is undergoing a rare test of its 'magic' following a drug trial failure, which has led to a significant slide in the company's share price.
24 Jul, 06:16 — 24 Jul, 06:16
Sources
Showing 1 of 1 sources
